Insulin resistance is an important risk factor in the development of cardiovascular diseases such as hypertension and atherosclerosis. However, despite its importance, the specific role of insulin resistance in the etiology of these diseases is poorly understood. At the same time, ethanol (ETOH) is a potent vasoconstrictor that primarily induces down regulation of mitogen activated protein kinases (MAPKs) which could exacerbate insulin resistance and possibly lead to cardiovascular diseases. This article describes how chronic ETOH exposure interferes with insulin signaling in hypertensive vascular smooth muscle cells (HVSMCs) which leads to the alteration of MAPKs, the major signaling molecules. Elevated (50 - 800 mM) chronic exposure (24 hr) of HVSMCS to ETOH prior to insulin stimulation decreased insulin-induced ERK 1/2 (MAPKs) and AKT expression. Similar experiments were conducted using normotensive cells from rat. These cells showed reductions in insulin-induced ERK 1/2 phosphorylation as well, but only at higher concentrations of ETOH (400 - 800 mM). These alterations in insulin signaling could provide an alternative molecular mechanism that may increase the risk of insulin resistance, thus increasing the possibility of cardiovascular diseases.
展开▼
机译:Retraction: Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF‐κB signalling pathway in rats with myocardial infarction. Dong‐Mei Wu, Yong‐Jian Wang, Xin‐Rui Han, Xin Wen, Lei Li, Lan Xu, Jun Lu and Yuan‐Lin Zheng. J Cell Mol Med. 2018; 22: 3058–3072 (https://doi.org/10.1111/jcmm.13557).
机译:Retraction: Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF‐κB signalling pathway in rats with myocardial infarction. Dong‐Mei Wu Yong‐Jian Wang Xin‐Rui Han Xin Wen Lei Li Lan Xu Jun Lu and Yuan‐Lin Zheng. J Cell Mol Med. 2018; 22: 3058–3072 (https://doi.org/10.1111/jcmm.13557).
机译:pathological mechanisms of systemic lupus erythematosus: toll-like receptors, intracellular signaling molecules, CD26, T helper 17 cells and B cell chemokine.